Gilead Sciences Inc.

(GILD) Trade

By |

Profile

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite acquisition boosted Gilead's exposure to cell therapy in oncology.

Contact Information

Website: www.gilead.com
Email: investor_relations@gilead.com
Main Phone: +1 650 574-3000
Address: 333 Lakeside Drive
State: CA
City / Town: Foster City
Country: USA
Postal Code: 94404

Issuer Information

Exchange: NGS
CEO: John F. Milligan
Employees: 10000
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 68.15 $ -2.04 (-2.91%)
Last Price 68.15 Change $ -2.04 Change % -2.91 Tick N/A
Bid 67.90 Bid Size 300.00 Ask 68.49 Ask Size 300.00
Open 69.78 High 70.00 Low 67.89 Prev Close 70.19
Last Trade Volume 5.7 mi 52 Wk Hi 89.54 52 Wk Low 64.27
Market Cap 88.2 bi Ex-Div Date Div Rate 2.28 Yield 3.3460
Shares 1,293,619,612.00 EPS (TTM) 1.23 PE Ratio 55.40 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 30 168
Number of Buys 15 79
Number of Sells 15 89
Net Activity 86723 -15903
Last 10 Buys Shares
Per Wold-Olsen 1,000
Per Wold-Olsen 1,000
Per Wold-Olsen 1,000
Carla A. Hills 1,000
Last 10 Sell Shares
John C. Martin 1,000
John F. Cogan 1,000
John C. Martin 1,000
John F. Cogan 1,000
John F. Cogan 1,000
John F. Cogan 1,000
John F. Cogan 1,000
John F. Cogan 1,000
John F. Cogan 1,000
John C. Martin 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 105 105 105 105
Low Target Price Estimate 72 72 72 72
Mean Target Price Estimate 87.53 87.71 87.71 87.53
Standard Deviation 8.15 8.43 8.43 8.15
Date of Most Recent Estimate 05/31/18 05/03/18 05/03/18 06/14/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 12 11 12 12
Moderate Buy 1 1 1 1
Hold 8 8 8 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.81 1.85 1.81 1.81